维普中文期刊产品整合服务
44篇 您的检索式:作者名="CARIOU G"
    题名 作者 年代 出处 被引量
1Hepatic PCSK9 expression is regulated by nutritional status via insulin and sterol regulatory element-binding protein lc 显示文摘Costet P Cariou B Lambert G 2006J Biol Chem2006,281,10:1
2Efficacy and safety of canagliflozin in subjects with type 2 diabetes and chronic kidney disease 显示文摘Yale J-F Bakris G Cariou B 2013Diabetes Obes Metab2013,15,5:1
3Efficacy and safety of eanagliflozin over 52 weeks in patients with type 2 diabetes mellitus and chronic kidney disease显示文摘Yale JF Bakris G Cariou B 2014Diabetes Obes Metab2014,16,10:1
4Efficacy and safety of canagliflozin in subjects with type 2 diabetes and chronic kidney disease显示文摘Yale JF Bakris G Cariou B 2013Diabetes Obes Metab2013,15,5:1
5Single-dose pharmacodynamics of clopidogrel显示文摘Thebault JJ Kieffer G Carious R 1999Semin Thromb Hemost1999,25,2:1
6Efficacy and safety of canagliflozin insubjects with type 2 diabetes and chronic kidney disease显示文摘Yale J F Bakris G Cariou B 2013Diabetes Obes Metab2013,15,5:1
7Single-dose pharmacodynamies of clopidogrel显示文摘Thebauh JJ Kieffer G Cariou R 1999Semin Thromb Hemost1999,252,:1
8Efficacy and safety of cana- gliflozin in subjects with type 2 diabetes and chronic kidney dis- ease显示文摘Yale JF Bakris G Cariou B 2013Diabetes Obes Metab2013,15,5:1
9Efficacy and safety of canagliflo- zin in subjects with type 2 diabetes and chronic kidney disease 显示文摘Yale JF Bakris G Cariou B 2013Diabetes Obes Metab2013,15,5:1
10Single-dose pharmacodynamics of clopidogrel 显示文摘Thebauh J J Kieffer G Cariou R 1999Semin Thromb Hemost1999,25,2:1
11Single-dose pharmaco- dynamics of clopidogrel显示文摘Thebault JJ Kieffer G Cariou R 1999Semin Thromb Hemost1999,25,2:1
12Single -dose pharmacodynamics of- clopidogrel 显示文摘Thebault JJ Kiefer G Cariou R 1999Semin Thromb Hemost1999,25,12:1
13Single-dose pharmacodynamics of clopidogrel显示文摘Thebault JJ Kiefer G Carious R 0,,2:1
14Single-dose phar- macodynamics of clopidogrei显示文摘THEBAULT JJ KIEFFER G CARIOUS R 1999Semin Thromb Hemost1999,25,2:1
15Efficacy and safety of eanagliflozin in subjects with type 2 diabetes and chronic kidney disease 显示文摘YALE JF BAKRIS G CARIOU B 2013Diabetes Obes Metab2013,15,5:1
16The coculture:a system for studying the regulation of liver differentiation/proliferation activity and its control显示文摘Corlu A llyin G Cariou S 1997Cell Biol Toxicol1997,13,45:1
17Efficacy and safety of canagliflo- zin in subjects with type 2 diabetes and chronic kidney disease 显示文摘Yale JF Bakris G Cariou B 2013Diabetes Obes Metab2013,15,5:1
18The mitogen-activated protein kinase kinase/extracellular signal-regulated kinase cascade activation is a key signalling pathway involved in the regulation of G1 phase progression in proliferating hepatocytes显示文摘Talarmin H Rescan C Cariou S Glaise D Zanninelli G Bilodeau M 1999Mol cell1999,19,9:1
19PCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia (RUTHERFORD-2): a randomised, double-blind, placebo-controlled trial显示文摘Frederick J Raal Evan A Stein Robert Dufour Traci Turner Fernando Civeira Lesley Burgess Gisle Langslet Russell Scott Anders G Olsson David Sullivan G Kees Hovingh Bertrand Cariou Ioanna Gouni-Berthold Ransi Somaratne Ian Bridges Rob Scott Scott M Wasserm 2015The Lancet . 2015 (9965)2015,,9965:1
20Efficacy and safety of canagli- flozin in subjects with type 2 diabetes and chronic kidney disease 显示文摘Yale JF Bakris G Cariou B 2013Diabetes Obes Metal)2013,15,5:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费